CeriBell, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
CeriBell, Inc. (CBLL) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 739.09 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-10
- CeriBell, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was 656.06K shares, a 24.89% increase year-over-year.
- CeriBell, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 83.03K shares, a 487.58% increase year-over-year.
- CeriBell, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 57.03K shares, a 47.91% decline year-over-year.
- CeriBell, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 0.00 shares.
- CeriBell, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 596.48K shares, a 67.28% decline from fiscal 2024.
- CeriBell, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 1.82M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|
| 2026-06-30 | 656.06K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | 739.09K shares 10-Q · filed 2026-08-10 | 796.12K shares derived: sum of 3 quarters · filed 2026-08-10 | 796.12K shares derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | 83.03K shares 10-Q · filed 2026-05-11 | 140.06K shares derived: sum of 2 quarters · filed 2026-05-11 | 140.06K shares derived: sum of 3 quarters · filed 2026-05-11 | 665.38K shares derived: sum of 4 quarters · filed 2026-05-11 |
| 2025-12-31 | 57.03K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | 57.03K shares derived: sum of 2 quarters · filed 2026-02-24 | 582.35K shares derived: sum of 3 quarters · filed 2026-02-24 | 596.48K shares 10-K · filed 2026-02-24 |
| 2025-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | 525.32K shares derived: sum of 2 quarters · filed 2025-11-04 | 539.45K shares 10-Q · filed 2025-11-04 | 648.95K shares derived: sum of 4 quarters · filed 2025-11-04 |
| 2025-06-30 | 525.32K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | 539.45K shares 10-Q · filed 2025-08-05 | 648.95K shares derived: sum of 3 quarters · filed 2025-08-05 | |
| 2025-03-31 | 14.13K shares 10-Q · filed 2025-05-08 | 123.63K shares derived: sum of 2 quarters · filed 2025-05-08 | ||
| 2024-12-31 | 109.50K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | 1.82M shares 10-K · filed 2025-02-25 | ||
| 2024-09-30 | 1.71M shares 10-Q · filed 2024-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |